Don’t Miss the Incredible Return Potential of Cirrus Logic, Inc. (CRUS)

Page 1 of 2

We all know that we live in a society where our lives and increasingly high standard of living are driven by rapid improvements in technology.  However, it is rare that, as investors, we have the opportunity to hold positions in the leading businesses in this arena, unless we are willing to pay exorbitant multiples of most standard metrics in order to acquire the shares.  As one who is only willing to buy what I believe to be substantially undervalued assets with enormous upside, created by widespread misperceptions in the broad market, this is simply not an arena where I normally allocate a great deal of capital.  However, when existing shareholders are willing to give away future earnings of a solid business that is in the process of effectively dealing with potentially problematic issues, I am willing to look hard at the opportunity.  I have found what I believe to be that exact situation with Cirrus Logic, Inc. (NASDAQ:CRUS) today; a leader in its industry, which is supplying high precision analog and digital signal processing components to the audio and energy industries.

Cirrus Logic, Inc. (NASDAQ:CRUS)

As of the market close yesterday, the price to earnings (PE) ratio for the current year is approximately 7.5, based on the consensus estimate of $3.26/share for the year ending March 2013.   With the consensus for 5-year annual earnings growth at 15%, this stock could easily support a stock price of $37 to $40 per share.  But this one gets even better!  The estimates for the current year (ending 3/13) and 2014 have been rising in the last 90 days!

Cirrus Logic has no long-term debt and only $138.95 million in total liabilities.  Against this amount, the business is holding $148.17 million in cash and short-term investments, $170.68 million in receivables and $135.02 million in inventory!  If you value the inventories and receivables at only 50%, the company covers ALL of its liabilities and still has $162 million dollars left over.  Considering Apple Inc (NASDAQ:AAPL) accounts for 90% of the company’s sales, it is highly unlikely that they will not collect almost all of their receivables and sell the vast majority of their existing inventory………unless you believe Apple is about to go out of business. In a purely financial sense, this one is a rock!  As they say in the infomercials:  “BUT WAIT!  THERE’S MORE!”

This is also a business that knows how to allocate its resources in a very efficient manner.  Over the last five years, they have produced annualized returns on equity, assets and capital of 22.5%, 19.1% and 21.9% respectively!  Those are exceptional numbers in today’s economic environment and they show that management doesn’t tolerate the waste of shareholder’s money and is very talented when it comes to generating attractive returns on that money.  This is a trait I love to see and is much too difficult to find.

Its two main publicly traded competitors are Texas Instruments Incorporated (NASDAQ:TXN) and STMicroelectronics N.V. (ADR) (NYSE:STM) . Based upon the same metrics used above, the numbers for these two businesses respectively are: ROE: 20.06% & -4.02%, respectively; ROA: 14.3% & -5.6%, respectively; ROC: 16.9% & -7.3%, respectively.  Cirrus compares very favorably with Texas Instruments on these metrics and they both are far superior to STM.  Cirrus is also allocating substantial amount of their free cash flow to retire outstanding shares of stock.  This practice quietly increases the value of the remaining shares, but is not something that typically shows up quickly in the stock price and creates opportunities for bargain hunters before the average investor catches on.

One last little thing about this business, they have maintained an average net profit margin of 23.8% over the last five years!  How many businesses do you know have accomplished that feat in the economic environment we have seen since 2007.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!